Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 7, 2025 (2 years ago)

Chlorambucil Container Description: The product packed in double…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.

Recalling firm
Aspen Biopharma Labs Pvt., Ltd.
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0263-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Aspen Biopharma Labs Pvt., Ltd.

All 2025 recalls

Other cgmp deviation recalls from 2025

All cgmp deviation recalls
Class II · Moderate risk

TPN bag (patient specific)

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Ongoing cGMP deviation Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles D-0524-2026
Class II · Moderate risk

Toothpaste: a) COLGATE

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0287-2026
Class II · Moderate risk

Deodorant: a) Axe

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0286-2026